NCT00055263View on ClinicalTrials.gov

A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 31, 2002

Conditions

Neoplasms

Interventions

DRUG

DN-101

Trial Locations (2)

14263

Roswell Park Cancer Institute, Buffalo

97201

Oregon Health & Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novacea

INDUSTRY